Excited to share our inaugural paper from the DILWALE South Asian CV Health Registry established by @AAgarwalaMD
🔗https://t.co/bGaynJKp6P
-31K adults (largest 🇺🇸 cohort)
-⬆️ RF burden: HTN,DM
-RFs highest in 🚹 & premature CVD
-HTN & HLD a/w 3.5x CVD risk
-🚺under Rx w LLT
We're pleased to announce Dr. Harlan M. Krumholz, a globally esteemed cardiologist and researcher, as the incoming editor-in-chief of #JACC!
Join us in celebrating his appointment and learn more about his incredible contributions to the field: https://t.co/yo2jhQPYlg @hmkyale
It is time again to recruit for our Cardiometabolic Fellowship in the Johns Hopkins Ciccarone Center. This is dedicated for those with SPECIFIC interest in preventive cardiology and cardiometabolic disease. If interested, please DM me and I will ask for your CV and PS.
FH pts, no clinical CAD, mean age 48 y; treated median 11 years, LDL-C 155 mg/dL. 42% CAC=0 & 33% no plaque in CTA, varying by age and sex. We Should use more imaging in FH to improve risk stratification
@FHFamiliar@HFIberoamerica@society_eas
https://t.co/tN8MRsaVPh
PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): prospective study protocol investigating prevalence, severity & determinants of atherosclerotic CVD in the young adult Pakistani pop… @BMJ_Open https://t.co/srlIt2PDQ7
🚨
📌CVD risk-stratification among persons w/ obesity is key esp in this era of expanded obesity pharmacotherapy
📌CAC may help identify optimal candidates for novel but costly anti-obesity medications @MichaelJBlaha@MichaelAlbertMD@rblument1@khurramn1
https://t.co/nHYRaWvVbR
CAC-PREVENTABLE is an exciting ancillary trial exploring the utility of coronary artery calcification (CAC) as a predictor for benefit of statin 💊 therapy in PREVENTABLE.
👏 Great talk by Dr. Melissa Daubert 👏
Status of #cvPrev training in the 🇺🇸—- not much 🤷🏻♀️
Excellent perspective and thought provoking questions by Dr. Maron….we have work to do! @ASPCardio#ASPC2023
Does Elevated High-Density Lipoprotein #HDL Cholesterol Protect Against Cardiovascular Disease? #cvprev
Led by 🌟FIT @AlexRazavi
https://t.co/pwmUdO6Azu
Incredibly excited to match @StanfordMedRes! Thank you to my family and the wonderful mentors I've had throughout my education for making this day possible: Susan Gurley, @Nephro_Sparks, @alenghat, @MichaelJBlaha. Thrilled to be joining the amazing program at Stanford!